神经瘤学试验中的临床结果评估趋势
Yeonju Kim1, Mark R Gilbert2, Terri S Armstrong2
1School of Medicine, Wayne State University, Detroit, Michigan.
Neuro-oncology practice
|December 29, 2025
概括
临床结果评估 (COA) 显示在神经瘤学试验中的使用较低,但越来越多. 需要努力在早期阶段和以治疗为重点的研究中改善COA的采用,以获得更好的患者结果.
科学领域:
- 神经瘤学神经瘤学
- 临床试验 临床试验
- 健康 结果 研究 研究 结果
背景情况:
- 临床结果评估 (COA) 对于评估癌症治疗,平衡生存与生活质量至关重要.
- 了解神经瘤学中COA的采用是非常重要的,因为患者的症状简介复杂.
研究的目的:
- 分析神经瘤学临床试验中临床结果评估 (COA) 的使用趋势和差距.
- 确定影响COA采用的因素以及监管和宣传工作的影响.
主要方法:
- 对神经瘤学试验的系统综述 在ClinicalTrials.gov.gov.
- 使用PROQOLID数据库识别COA仪器.
- 相关性和回归分析以评估趋势和关联.
主要成果:
- 在1874项神经瘤学试验中,只有16%使用了COA,患者报告结果 (71%) 和临床医生报告结果 (46%) 是最常见的.
- 随着时间的推移,COA的使用增加,并与后期,支持性护理,新型干预,多臂和随机试验相关.
- 在大多数COA类型中,COA的纳入量显著增加,特别是在以治疗为重点的研究中.
结论:
- 神经瘤学试验显示,COA的采用率较低,但越来越高,反映了更广泛的瘤学趋势.
- 在早期试验,FDA批准的干预研究和以治疗为重点的研究中需要改进.
- 加强COA报告标准化对于推进神经瘤学研究至关重要.
相关概念视频
Cancer Survival Analysis
626
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
626
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
376
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
376
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


